TRAM1

TRAM1 is an eight-transmembrane ER glycoprotein that functions downstream of Sec61α in the co-translational translocation pathway, facilitating the insertion of nascent secretory and membrane protein chains into the ER membrane in a signal sequence–dependent manner (PMID:8698819). In reconstituted proteoliposomes, TRAM1 is dispensable for initial ribosome–nascent chain docking but essential for the subsequent step in which the nascent chain achieves protease-resistant insertion at the translocation site, with its requirement dictated by the hydrophobicity and charged-region length of the signal sequence (PMID:8698819). Photocrosslinking studies show that during integration of multi-spanning membrane proteins, each transmembrane segment first contacts Sec61α and then sequentially engages TRAM1 for an extended period, indicating that TRAM1 acts as a downstream acceptor for transmembrane domains exiting the translocon (PMID:17169373).

1. 1996 High

   Resolved whether TRAM1 participates in ribosome docking or a later translocation step: TRAM1 is dispensable for SRP-mediated targeting but essential for subsequent signal sequence–dependent nascent chain insertion, establishing it as a translocation-competence factor rather than a targeting factor.

   Evidence Reconstituted proteoliposomes with purified SRP, SR, Sec61, and TRAM1; protease protection assay with hybrid signal sequences

   PMID:8698819

   Open questions at the time

   • Molecular mechanism by which signal sequence features determine TRAM1 dependence is unknown
   • No structural information on TRAM1–nascent chain contacts
   • Role in membrane protein (versus secretory protein) integration not yet examined
2. 2006 High

   Established the sequential order of translocon contacts during multi-spanning membrane protein integration: each transmembrane segment first contacts Sec61α and then transfers to TRAM1, positioning TRAM1 as a downstream acceptor that holds TM segments after their exit from the Sec61 channel.

   Evidence Site-specific photocrosslinking during in vitro translation of a double-spanning viral membrane protein with TM segment variants

   PMID:17169373

   Open questions at the time

   • Whether TRAM1 directly facilitates lateral release of TM segments into the lipid bilayer is untested
   • Stoichiometry and dynamics of TRAM1–Sec61 interaction during integration remain uncharacterized
3. 2011 High

   Defined the membrane topology of TRAM1 itself as an eight-transmembrane glycoprotein containing several poorly hydrophobic TM segments, providing the first structural framework for understanding how it engages nascent chains.

   Evidence Photocrosslinking and C-terminal glycosylation/protease-accessibility reporter fusions validated in mammalian cells

   PMID:21237175

   Open questions at the time

   • No high-resolution structure of TRAM1 or TRAM1–translocon complex
   • Which of the eight TM segments form the nascent chain contact surface is unknown
4. 2015 Medium

   Identified a non-canonical role for TRAM1 in innate immune signaling: TRAM1 is induced by LPS/IFN-γ in microglia and is required for TLR4-mediated activation of NF-κB and IRF3, promoting M1 polarization.

   Evidence siRNA knockdown and overexpression in BV2 and primary microglia; western blot for IRAK1, p-TBK1, p-IRF3, p-IκB, p-p65; immunofluorescence for NF-κB nuclear translocation

   PMID:26563450

   Open questions at the time

   • Single-lab finding not independently replicated
   • Whether the TLR4 signaling role depends on TRAM1's translocation function or is mechanistically distinct is unresolved
   • Physical interaction between TRAM1 and TLR4 pathway components not demonstrated

• A high-resolution structure of TRAM1 in the context of the Sec61 translocon is needed to explain how signal sequence features and TM segment properties determine TRAM1 dependence, and whether its reported immune signaling function is mechanistically linked to its translocation role.
• No cryo-EM or crystal structure of TRAM1 alone or in complex
• In vivo loss-of-function phenotype in mammalian models not reported
• Mechanism coupling TRAM1 to TLR4 pathway activation remains undefined